Last Updated: 10/03/2026
Target Malaria Ac(PMB) trial support
Objectives
To fund the trial release and monitoring of self-limited GM (genetically modified) mosquitoes.
On 11 August 2025, one small scale release of non gene drive genetically modified male bias mosquitoes took place successfully, in accord with terms and conditions of the ANB and ANEVE permits.
On 18 August, the national authorities requested the Target Malaria team at IRSS to suspend all their activities. The IRSS team complied with the request.
On 22 August, the Ministry of Higher Education, Research and Innovation issued a communiqué informing “the Burkinabè public that it has terminated all the activities of the project Target Malaria on its territory”.
Sep 2024 — Sep 2028
$5.65M


